InsidersTradesSigma
Follow the ACTINOGEN MEDICAL LIMITED share price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the oversight of ASX. The latest transaction was disclosed on 28 August 2026 (Mixed). Among the most active insiders: Dr George Morstyn. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
ACTINOGEN MEDICAL LIMITED is a company focused on developing treatments for neurodegenerative diseases, particularly Alzheimer's disease. It is listed on the XASX market.